References
Chung DC. Molecular prognostic markers and colorectal cancer: the search goes on. Gastroenterology 1998;114:1330–8.
Gryfe R, Kim H, Hsieh ET,et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med 2000;342:69–77.
Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. Molecular biology of colorectal cancer. Curr Probl Cancer 1997;21:233–300.
Shibata D, Reale MA, Lavin P,et al. The DCC protein and prognosis in colorectal cancer. N Engl J Med 1996;335:1727–32.
Carethers JM, Hawn MT, Greenson JK, Hitchcock CL, Boland CR. Prognostic significance of allelic lost at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 1998;114:1188–95.
Elsaleh H, Powell B, Soontrapornchai P,et al. p53 gene mutation, microsatellite instability and adjuvant chemotherapy: impact survival of 388 patients with Dukes' C colon carcinoma. Oncology 2000;58:52–9.
Author information
Authors and Affiliations
About this article
Cite this article
Smith, A.J., Gallinger, S., Wexner, S.D. et al. Invited editorial. Dis Colon Rectum 44, 372–373 (2001). https://doi.org/10.1007/BF02234735
Issue Date:
DOI: https://doi.org/10.1007/BF02234735